NCT06958627
- Conditions
- HER2 Positive Breast Cancer, Pyrotinib Treatment
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying HER2 Positive Breast Cancer. Study availability and eligibility vary by location and protocol.
NCT06958627
NCT01785420
NCT06868017
Not specified
NCT02705859
NCT04539938
NCT01840306
NCT03013504
NCT02476539
NCT02614794
NCT03735966